Cc1cc(/C=C2\SC(=O)N(C)C2=O)c(C)n1-c1ccc(S(N)(=O)=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?